Previous Next

2024-02-26

Persistent HIV-1 controllers

Infectiology

In persistent controllers, HIV-1 control is maintained indefinitely in the absence of antiretroviral therapy. In transient controllers, virological control is only temporary. In this study, researchers assessed the HIV-1 reservoir in these two phenotypes to identify factors predicting HIV progression. In both phenotypes, total, intact and defective proviruses were found in lower quantities than in patients on antiretroviral therapy. Intact provirus levels were lower in persistent than in transient controls. The ratio of intact to defective HIV-DNA was significantly higher in transient controls.

Source(s) :
Carmen Gasca-Capote et al. The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers. J Clin Invest. 2024 Feb 20:e174215. ;

Last press reviews


Gene therapy: a turning point for parkinson’s disease?

By Ana Espino | Published on April 7, 2026 | 4 min read<br><br><br>

Breast cancer: circulating tumor DNA, a key biomarker to anticipate relapse

By Elodie Vaz | Published on April 3, 2026 | 3 min read<br><br><br>B...

Gut microbiota: metabolites at the heart of cardiovascular risk

By Elodie Vaz | Published on April 3, 2026 | 4 min read<br><br><br>C...